About Bioplus Life Sciences
Bioplus Life Sciences is a company based in Bengaluru (India) founded in 2004 by Sundeep Aurora. It operates as a Professional Services and HealthTech. Bioplus Life Sciences has raised $29.37 million across 1 funding round from investors including AIF Capital. The company has 276 employees as of April 07, 2024. Bioplus Life Sciences offers products and services including 7-MX and Nutraceutical Products.
- Headquarter Bengaluru, India
- Employees 276 as on 07 Apr, 2024
- Founders Sundeep Aurora
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioplus Life Sciences
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$15.67 M (USD)5.82as on Mar 31, 2022
-
Net Profit
$1.63 M (USD)728.61as on Mar 31, 2022
-
EBITDA
$2.46 M (USD)385.81as on Mar 31, 2022
-
Total Equity Funding
$29.37 M (USD)
in 1 rounds
-
Latest Funding Round
$29.37 M (USD), Series B
Jun 06, 2008
- Investors
-
Employee Count
276
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioplus Life Sciences
Bioplus Life Sciences offers a comprehensive portfolio of products and services, including 7-MX and Nutraceutical Products.
Developed for pediatric myopia control as therapeutic solution.
Formulated to support health through innovative food ingredients.
People of Bioplus Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Bioplus Life Sciences
Bioplus Life Sciences has successfully raised a total of $29.37M through 1 strategic funding round. The most recent funding activity was a Series B round of $29.37 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioplus Life Sciences
Bioplus Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include AIF Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funding and expertise for emerging businesses in Asia.
|
Locked | Locked | Locked |
Investor details for Bioplus Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioplus Life Sciences
Investment portfolio details for Bioplus Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioplus Life Sciences
Detailed financials for Bioplus Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioplus Life Sciences Comparisons
Peer comparison for Bioplus Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioplus Life Sciences
Detailed competitors of Bioplus Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioplus Life Sciences
Complete news archive for Bioplus Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioplus Life Sciences
Bioplus Life Sciences was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Bioplus Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Sundeep Aurora is the current CEO of Bioplus Life Sciences. They have also founded this company.
Bioplus Life Sciences is a funded company, having raised a total of $29.37M across 1 funding round to date.
As of Apr 07, 2024, the latest employee count at Bioplus Life Sciences is 276.
Annual revenue of Bioplus Life Sciences is $15.67M as on Mar 31, 2022.
Bioplus Life Sciences is focused on the development of innovative therapeutics for global unmet medical needs, particularly in ophthalmology. The company is involved in research and development of novel drugs like 7-MX for pediatric myopia control. Additionally, solutions are provided in nutraceuticals and dietary supplements. Operations span across clinical and pre-clinical stages, with a presence in over 50 countries. Advanced technology and extensive research are utilized to enhance product and service quality in the healthcare sector.
Bioplus Life Sciences offers 7-MX and Nutraceutical Products.
Bioplus Life Sciences has 1 investor. Key investors include AIF Capital.
The valuation of Bioplus Life Sciences is $321.18M as of Jun 2008.